CONMED Corporation

CNMD - Financial Snapshot

Healthcare sector | Medical Devices industry

View on:

Ranks:

Metrics for CNMD

Price	$46.0
Shares Outstanding	30.83M
All-Time Low	$0.81
52-Week Low	$35.37

Balance Statement Metrics

Net Cash / Share	$0 cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
Net Current Assets / Share	$-20.1 netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
Net Tangible Assets / Share	$0 netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
Shares Outstanding Ave Change (Annual)	1.7%
Shares Δ YoY	0.44%
Avg CA Burn (Annual %)	12.07% (as of 3-1-2026)
Avg CA Burn (Quarterly %)	1.27% (as of 3-1-2026)

Earning Metrics

Max Earning Power / Share	$17.13 maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
Adjusted Earning Power	$5.17 adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
Non-Cash Charges to Market Cap	1.32% nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Avg EBITDA (5Y)	167.9M (as of 3-1-2026)
Avg EBITDA (5Q)	49.4M (as of 3-1-2026)
Avg Net Income (5Y)	44.7M (as of 3-1-2026)
Avg Net Income (5Q)	16.2M (as of 3-1-2026)

Data as of: Price 02-27-26 16:00 ET, Balance Sheet 2025-12-31, Income Statement 2025-12-31, Cash Flow 2025-12-31

Indicators

Dividend indicators	Value	Date
Current Dividend Streak	Yes	3-1-2026
Consecutive Years Paid	14 years	3-1-2026
Pays Dividend	Yes	3-1-2026
Dividend Type	common	3-1-2026
Dividend Payout / Share	$0.20	3-1-2026
Last Dividend Date	10-2-25

Income indicators	Value	Date
EBITDA Positive	Yes	3-1-2026
Net Income Positive	Yes	3-1-2026
Current Dividend Streak	Yes	3-1-2026

Metric History Explorer

Pick a metric to view its history table and chart.

Tangible Book Value Per Share History

Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.

Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).

Report Date	Period	TBV / Share	Tangible Book Value	Shares Used
2025-12-31	Quarterly	$-11.49	-356M ($-355,965,000)	31M (30,971,097)
2025-09-30	Quarterly	$-12.66	-391.8M ($-391,760,000)	31M (30,955,051)
2025-06-30	Quarterly	$-13.12	-405.9M ($-405,873,000)	30.9M (30,946,290)
2025-03-31	Quarterly	$-14.16	-437.9M ($-437,894,000)	30.9M (30,929,767)
2024-12-31	Quarterly	$-14.90	-460.3M ($-460,340,000)	30.9M (30,901,334)
2024-12-31	Annual	$-14.90	-460.3M ($-460,340,000)	30.9M (30,901,334)
2024-09-30	Quarterly	$-16.17	-499.5M ($-499,544,000)	30.9M (30,884,686)
2023-12-31	Annual	$-20.22	-622.1M ($-622,106,000)	30.8M (30,765,194)
2022-12-31	Annual	$-24.66	-751.7M ($-751,683,000)	30.5M (30,487,662)
2021-12-31	Annual	$-10.32	-303.1M ($-303,142,000)	29.4M (29,373,301)

Revenue History (Annual)

Revenue from income statements. Includes 4 annual.

Chart plots one annual Revenue point per report date.

Report Date	Revenue
2024-12-31	1.3B ($1,307,015,000)
2023-12-31	1.2B ($1,244,744,000)
2022-12-31	1B ($1,045,472,000)
2021-12-31	1B ($1,010,635,000)

Dividend Payments

Historical cash dividends per share from Yahoo ex-dividend dates.

Date	Dividend / Share
2025-09-15	$0.2
2025-06-13	$0.2
2025-03-14	$0.2
2024-12-20	$0.2
2024-09-16	$0.2

Show 50 older dividend payments

Date	Dividend / Share
2024-06-14	$0.2
2024-03-14	$0.2
2023-12-15	$0.2
2023-09-14	$0.2
2023-06-14	$0.2
2023-03-14	$0.2
2022-12-15	$0.2
2022-09-14	$0.2
2022-06-14	$0.2
2022-03-14	$0.2
2021-12-14	$0.2
2021-09-14	$0.2
2021-06-14	$0.2
2021-03-12	$0.2
2020-12-14	$0.2
2020-09-14	$0.2
2020-06-12	$0.2
2020-03-13	$0.2
2019-12-12	$0.2
2019-09-12	$0.2
2019-06-13	$0.2
2019-03-14	$0.2
2018-12-13	$0.2
2018-09-13	$0.2
2018-06-14	$0.2
2018-03-14	$0.2
2017-12-14	$0.2
2017-09-14	$0.2
2017-06-13	$0.2
2017-03-13	$0.2
2016-12-13	$0.2
2016-09-13	$0.2
2016-06-13	$0.2
2016-03-11	$0.2
2015-12-11	$0.2
2015-09-11	$0.2
2015-06-11	$0.2
2015-03-12	$0.2
2014-12-11	$0.2
2014-09-11	$0.2
2014-06-12	$0.2
2014-03-13	$0.2
2013-12-12	$0.2
2013-09-12	$0.15
2013-06-13	$0.15
2013-03-13	$0.15
2012-12-13	$0.15
2012-09-12	$0.15
2012-06-13	$0.15
2012-03-13	$0.15

Shares Outstanding Changes

Date	Shares Outstanding	Delta
2026-02-24	30,833,536	-134,418

Short Interest Changes

Latest short-interest change: 2,052,417 shares (9.10% of float) | Days to cover: 3.22

Date	Short Interest	Delta	Δ %
2026-02-26	2,052,417 shares	-218,667	-9.63%
2026-02-11	2,271,084 shares	-53,559	-2.30%

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date	Volume	Shares Outstanding	Volume / Shares	Price
No interesting volume events

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.